Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Drug combo safely decreases pancreatic cancer growth in mice

Drug combo safely decreases pancreatic cancer growth in mice

Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

New method can help researchers map pancreatic cancer development

New method can help researchers map pancreatic cancer development

Real-time live tissue sensitivity assay could be used as a personalized strategy for pancreatic cancer

Real-time live tissue sensitivity assay could be used as a personalized strategy for pancreatic cancer

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Unlocking the secret drivers of deadly pancreatic cancer: New target offers hope for treatment

Unlocking the secret drivers of deadly pancreatic cancer: New target offers hope for treatment

NCCN publishes new guideline focused on preventing and treating cancer-associated blood clots

NCCN publishes new guideline focused on preventing and treating cancer-associated blood clots

Enhanced recovery program shows promise in reducing opioid reliance after pancreatic cancer surgery

Enhanced recovery program shows promise in reducing opioid reliance after pancreatic cancer surgery

New liquid biopsy technology uses RNA "dark matter" to detect cancer

New liquid biopsy technology uses RNA "dark matter" to detect cancer

New research sheds light on role of KRAS mutations in pancreatic cancer

New research sheds light on role of KRAS mutations in pancreatic cancer

Lorazepam linked to shorter progression-free survival in pancreatic cancer patients

Lorazepam linked to shorter progression-free survival in pancreatic cancer patients

Researchers receive DoD grant to target chemotherapy resistance in pancreatic cancer

Researchers receive DoD grant to target chemotherapy resistance in pancreatic cancer

High cardiorespiratory fitness may protect against 9 types of cancer in men

High cardiorespiratory fitness may protect against 9 types of cancer in men

Study finds way to reverse gene silencing in inner ear cells

Study finds way to reverse gene silencing in inner ear cells

Virginia Tech researchers receive $2.6M NIH grant to study new pancreatic cancer treatment

Virginia Tech researchers receive $2.6M NIH grant to study new pancreatic cancer treatment

New gene-editing tool helps to study single-base mutations in cancer

New gene-editing tool helps to study single-base mutations in cancer

What are some recent advancements in proteomics-driven pancreatic oncology research?

What are some recent advancements in proteomics-driven pancreatic oncology research?

Computational model can help identify the sites of origin for enigmatic cancers

Computational model can help identify the sites of origin for enigmatic cancers

Study discloses vital role of LINC00901 and its regulatory network in pancreatic cancer progression

Study discloses vital role of LINC00901 and its regulatory network in pancreatic cancer progression

New study finds no link between common fungus and pancreatic cancer

New study finds no link between common fungus and pancreatic cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.